Werewolf Therapeutics Stock (NASDAQ: HOWL) stock price, news, charts, stock research, profile.
Open | $5.790 |
Close | - |
Volume / Avg. | 53.187K / 242.429K |
Day Range | 5.620 - 5.920 |
52 Wk Range | 1.574 - 8.194 |
Market Cap | $261.385M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 1.87% |
Days to Cover | 3.3 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Werewolf Therapeutics (NASDAQ: HOWL) through any online brokerage.
Other companies in Werewolf Therapeutics’s space includes: Adverum Biotechnologies (NASDAQ:ADVM), Inozyme Pharma (NASDAQ:INZY), Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP) and Opthea (NASDAQ:OPT).
The latest price target for Werewolf Therapeutics (NASDAQ: HOWL) was reported by JMP Securities on Wednesday, April 3, 2024. The analyst firm set a price target for 12.00 expecting HOWL to rise to within 12 months (a possible 104.60% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Werewolf Therapeutics (NASDAQ: HOWL) is $5.865 last updated Today at April 19, 2024 at 12:16 PM EDT.
There are no upcoming dividends for Werewolf Therapeutics.
Werewolf Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Werewolf Therapeutics.
Werewolf Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.